Lexicon Pharmaceuticals, Inc.
LXRX· Nasdaq
LXRXLexicon Pharmaceuticals, Inc.
Quarterly figures for Lexicon Pharmaceuticals, Inc., with source filings when available.
57 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
Lexicon Pharmaceuticals, Inc. has filed its 10-Q within 32 to 44 days of period end across its last 8 quarters. The 10-K runs 62 to 85 days.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · pre-market | Aug 6, 2026 | 37 d | 10-Q | $692.00K | −97.6% | -$0.07 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 7, 2026 · pre-market |
| May 7, 2026 |
| 37 d |
| 10-Q |
| $21.10M |
| +1,572.1% |
| $0.00 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 5, 2026 · pre-market | Mar 5, 2026 | 64 d | 10-K | $5.49M | +254.4% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · pre-market | Nov 6, 2025 | 37 d | 10-Q | $14.18M | +714.6% | -$0.04 | |
| Q2 2025 | Jun 30, 2025 | Aug 6, 2025 · pre-market | Aug 6, 2025 | 37 d | 10-Q | $28.87M | +1,685.2% | $0.01 | |
| Q1 2025 | Mar 31, 2025 | May 13, 2025 · after-hours | May 14, 2025 | 44 d | 10-Q | $1.26M | +15.5% | -$0.07 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 6, 2025 · after-hours | Mar 7, 2025 | 66 d | 10-K | $1.55M | +131.0% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 · after-hours | Nov 13, 2024 | 44 d | 10-Q | $1.74M | +1,076.4% | -$0.18 | |
| Q2 2024 | Jun 30, 2024 | Aug 1, 2024 · after-hours | Aug 2, 2024 | 33 d | 10-Q | $1.62M | +455.7% | -$0.17 | |
| Q1 2024 | Mar 31, 2024 | May 2, 2024 · after-hours | May 2, 2024 | 32 d | 10-Q | $1.09M | — | -$0.20 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 11, 2024 · pre-market | Mar 25, 2024 | 85 d | 10-K | $671.00K | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 8, 2023 · pre-market | Nov 8, 2023 | 39 d | 10-Q | $148.00K | — | -$0.21 | |
| Q2 2023 | Jun 30, 2023 | Aug 3, 2023 · after-hours | Aug 4, 2023 | 35 d | 10-Q | $291.00K | — | -$0.22 | |
| Q1 2023 | Mar 31, 2023 | May 2, 2023 · after-hours | May 4, 2023 | 34 d | 10-Q | $0.00 | — | -$0.17 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 2, 2023 · after-hours | Mar 3, 2023 | 62 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 9, 2022 · after-hours | Nov 9, 2022 | 40 d | 10-Q | $0.00 | — | -$0.13 | |
| Q2 2022 | Jun 30, 2022 | Aug 2, 2022 · after-hours | Aug 3, 2022 | 34 d | 10-Q | $0.00 | — | — | |
| Q1 2022 | Mar 31, 2022 | May 5, 2022 · pre-market | May 5, 2022 | 35 d | 10-Q | — | — | — | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 28, 2022 · pre-market | Mar 10, 2022 | 69 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 9, 2021 | 40 d | 10-Q | $0.00 | — | -$0.16 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 6, 2021 | 37 d | 10-Q | $0.00 | — | — | |
| Q1 2021 | Mar 31, 2021 | — | May 6, 2021 | 36 d | 10-Q | $0.00 | — | — | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 12, 2021 | 71 d | 10-K | $23.37M | +167.8% | — | |
| Q3 2020 | Sep 30, 2020 | — | Oct 30, 2020 | 30 d | 10-Q | $0.00 | −100.0% | $0.71 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Mar 12, 2020 | 72 d | 10-K | $8.73M | — | -$0.48 | |
| Q3 2019 | Sep 30, 2019 | — | Nov 7, 2019 | 38 d | 10-Q | $285.91M | — | $1.95 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2017 | — | Mar 1, 2018 | 60 d | 10-K | -$41.83M | N/M | — | |
| Q3 2016 | Sep 30, 2017 | — | Nov 8, 2017 | 39 d | 10-Q | $27.67M | −0.2% | -$0.28 | |
| Q2 2016 | Jun 30, 2017 | — | Aug 1, 2017 | 32 d | 10-Q | $12.09M | −39.8% | -$0.33 | |
| Q1 2016 | Mar 31, 2017 | — | May 4, 2017 | 34 d | 10-Q | $17.96M | +43.8% | -$0.31 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2016 | — | Mar 6, 2017 | 65 d | 10-K | $23.04M | −81.9% | -$0.31 | |
| Q3 2015 | Sep 30, 2016 | — | Nov 7, 2016 | 38 d | 10-Q | $27.72M | +4,797.0% | -$0.35 | |
| Q2 2015 | Jun 30, 2016 | — | Aug 4, 2016 | 35 d | 10-Q | $20.09M | +5,242.8% | -$0.37 | |
| Q1 2015 | Mar 31, 2016 | — | May 5, 2016 | 35 d | 10-Q | $12.49M | +597.2% | -$0.34 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2015 | — | Mar 11, 2016 | 71 d | 10-K | $127.28M | +492.5% | $0.76 | |
| Q3 2014 | Sep 30, 2015 | — | Nov 9, 2015 | 40 d | 10-Q | $566.00K | +35.1% | -$0.34 | |
| Q2 2014 | Jun 30, 2015 | — | Aug 7, 2015 | 38 d | 10-Q | $376.00K | −44.4% | -$0.27 | |
| Q1 2014 | Mar 31, 2015 | — | May 5, 2015 | 35 d | 10-Q | $1.79M | +546.9% | -$0.27 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 31, 2014 | — | Mar 12, 2015 | 71 d | 10-K | $21.48M | +1,423.5% | -$0.03 | |
| Q3 2013 | Sep 30, 2014 | — | Nov 6, 2014 | 37 d | 10-Q | $419.00K | +76.1% | -$0.55 | |
| Q2 2013 | Jun 30, 2014 | — | Aug 7, 2014 | 38 d | 10-Q | $676.00K | +215.9% | -$0.35 | |
| Q1 2013 | Mar 31, 2014 | — | May 8, 2014 | 38 d | 10-Q | $277.00K | −23.1% | -$0.42 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012 | Dec 31, 2013 | — | Mar 7, 2014 | 66 d | 10-K | $1.41M | +546.8% | -$0.03 | |
| Q3 2012 | Sep 30, 2013 | — | Nov 12, 2013 | 43 d | 10-Q | $238.00K | −36.0% | -$0.06 | |
| Q2 2012 | Jun 30, 2013 | — | Aug 1, 2013 | 32 d | 10-Q | $214.00K | +7.5% | -$0.06 | |
| Q1 2012 | Mar 31, 2013 | — | May 10, 2013 | 40 d | 10-Q | $360.00K | +20.0% | -$0.05 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011 | Dec 31, 2012 | — | Mar 11, 2013 | 70 d | 10-K | $218.00K | −36.4% | -$0.05 | |
| Q3 2011 | Sep 30, 2012 | — | Nov 7, 2012 | 38 d | 10-Q | $372.00K | +4.8% | -$0.06 | |
| Q2 2011 | Jun 30, 2012 | — | Aug 2, 2012 | 33 d | 10-Q | $199.00K | −64.1% | -$0.05 | |
| Q1 2011 | Mar 31, 2012 | — | May 3, 2012 | 33 d | 10-Q | $300.00K | −49.7% | -$0.06 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010 | Dec 31, 2011 | — | Mar 8, 2012 | 68 d | 10-K | $343.00K | — | -$0.10 | |
| Q3 2010 | Sep 30, 2011 | — | Nov 1, 2011 | 32 d | 10-Q | $355.00K | −54.5% | -$0.08 | |
| Q2 2010 | Jun 30, 2011 | — | Aug 9, 2011 | 40 d | 10-Q | $555.00K | −55.0% | -$0.08 | |
| Q1 2010 | Mar 31, 2011 | — | May 5, 2011 | 35 d | 10-Q | $596.00K | — | -$0.09 | |
| FY 2009 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2009derived | Dec 31, 2010 | — | Mar 16, 2011 | 75 d | 10-K | — | — | — | |
| Q3 2009 | Sep 30, 2010 | — | Nov 8, 2010 | 39 d | 10-Q | $781.00K | — | -$0.08 | |
| Q2 2009 | Jun 30, 2010 | — | Aug 9, 2010 | 40 d | 10-Q | $1.23M | — | -$0.07 | |
